We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$336M
AUM Growth
-$64.6M
Cap. Flow
-$15.1M
Cap. Flow %
-4.5%
Top 10 Hldgs %
79.42%
Holding
82
New
2
Increased
7
Reduced
6
Closed
7
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.5 years
Top 20 Avg Time Held
2.2 years

Top Buys

Rank Stock Value
1
GPGI icon
GPGI Inc
GPGI
+$5.32M
2
TALK icon
Talkspace
TALK
+$2.16M
3
MSAI icon
MultiSensor AI
MSAI
+$1.98M
4
PROK icon
ProKidney
PROK
+$1.64M
5
DMAC icon
DiaMedica Therapeutics
DMAC
+$439K

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.95%
2 Industrials 18.39%
3 Healthcare 14.98%
4 Materials 11.89%
5 Financials 11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MSAI icon
26
MultiSensor AI
MSAI
$9.48M
$1.33M 0.39%
+20,200
New +$1.98M
2024 Q2
0 quarters
LSXMK icon
27
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$1.22M 0.36%
55,216
– –
2019 Q4
18 quarters
RCAT icon
28
Red Cat Holdings
RCAT
$751M
$1.15M 0.34%
1,000,000
– –
2023 Q4
2 quarters
DMAC icon
29
DiaMedica Therapeutics
DMAC
$434M
$1.13M 0.34%
382,317
+160,000
+72% +$439K
2023 Q2
4 quarters
PROF icon
30
Profound Medical
PROF
$231M
$1.12M 0.33%
133,333
– –
2023 Q4
2 quarters
MODD icon
31
Modular Medical
MODD
$21M
$1.11M 0.33%
23,333
– –
2024 Q1
1 quarter
BLUE icon
32
DELISTED
bluebird bio
BLUE
$1.02M 0.3%
51,869
– –
2023 Q3
3 quarters
MXCT icon
33
MaxCyte
MXCT
$133M
$1.02M 0.3%
250,000
– –
2021 Q3
11 quarters
IPWR icon
34
Ideal Power
IPWR
$53.6M
$939K 0.28%
133,000
– –
2024 Q1
1 quarter
LBTYK icon
35
Liberty Global Class C
LBTYK
$2.69B
$621K 0.18%
34,809
-34,809
-50% -$606K
2019 Q4
18 quarters
RTX icon
36
RTX Corp
RTX
$252B
$602K 0.18%
6,000
– –
2020 Q2
16 quarters
LSXMA icon
37
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$536K 0.16%
24,197
– –
2020 Q2
16 quarters
LLYVK icon
38
Liberty Live Group Series C
LLYVK
$9.17B
$528K 0.16%
13,802
– –
2023 Q3
3 quarters
ICCC icon
39
ImmuCell
ICCC
$97.9M
$493K 0.15%
101,594
– –
2021 Q2
12 quarters
ONDS icon
40
Ondas Inc
ONDS
$3.71B
$450K 0.13%
775,000
– –
2021 Q3
11 quarters
EVOK icon
41
DELISTED
Evoke Pharma
EVOK
$436K 0.13%
68,750
– –
2024 Q1
1 quarter
GPCR icon
42
Structure Therapeutics
GPCR
$1.58B
$393K 0.12%
10,000
+5,000
+100% +$205K
2023 Q4
2 quarters
CARR icon
43
Carrier Global
CARR
$45.4B
$378K 0.11%
6,000
– –
2020 Q2
16 quarters
LHX icon
44
L3Harris
LHX
$44.9B
$359K 0.11%
1,600
– –
2019 Q4
18 quarters
PYPL icon
45
PayPal
PYPL
$48.9B
$308K 0.09%
5,300
– –
2020 Q1
17 quarters
OTIS icon
46
Otis Worldwide
OTIS
$26.8B
$289K 0.09%
3,000
– –
2020 Q2
16 quarters
LLYVA icon
47
Liberty Live Group Series A
LLYVA
$8.87B
$227K 0.07%
6,047
– –
2023 Q3
3 quarters
PHYS icon
48
Sprott Physical Gold
PHYS
$15B
$226K 0.07%
12,540
– –
2019 Q4
18 quarters
LBTYA icon
49
Liberty Global Class A
LBTYA
$2.74B
$200K 0.06%
11,495
-11,494
-50% -$194K
2019 Q4
18 quarters
CRIS icon
50
Curis
CRIS
$1.28M
$172K 0.05%
1,250
– –
2020 Q4
14 quarters

Similar funds

Bleichroeder LP's Q2 2024 Portfolio in Review

As of Q2 2024, Bleichroeder LP held 82 positions worth $336M, down 16% from $401M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Bleichroeder LP withdrew a net $15.1M in Q2 2024, closing 7 positions and reducing 6 holdings. Its most notable exit was Insmed, an estimated $8.82M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Bleichroeder LP opened a new position in MultiSensor AI worth $1.33M.

  • Bleichroeder LP's largest Q2 2024 buy was MultiSensor AI: 20,200 shares worth $1.33M.
  • Bleichroeder LP added most to GPGI Inc in Q2 2024, an estimated $5.32M increase.
  • Bleichroeder LP's biggest Q2 2024 reduction was Brunswick, cutting an estimated $14.3M.
  • Bleichroeder LP fully exited Insmed in Q2 2024, selling an estimated $8.82M.
  • Bleichroeder LP's ten largest holdings make up 79% of its $336M portfolio in Q2 2024.
  • Bleichroeder LP opened 2 new positions and closed 7 in Q2 2024.
  • Bleichroeder LP's portfolio value fell 16% quarter-over-quarter to $336M.

Based on Bleichroeder LP's 13F filing for Q2 2024, filed 13 Aug 2024.